1
TITLE: A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EUICD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
2
TITLE: Is treatment of cervical dystonia patients with botulinum toxin type B affected by a previous response to a botulinum toxin type A? Analysis of a long-term open-label study (AN072-401 EU/CD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Terry Germanson; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
3
TITLE: Botulinum toxin type A (Botox) versus botulinum toxin type B (Myobloc) in subjects with cervical dystonia: A comparison of the frequency of xerostomia and dysphagia (AN072-402 EU/CD)  Full Text
AUTHORS: Eric Pappert; Terry Germanson; Peter P Moore; Joaquim Ferreira;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
4
TITLE: The effects of repeated dosing of botulinum toxin type B (neurobloc (R)) in patients with cervical dystonia previously naive to botulinum toxin: An open-label extension study (AN072-402 EU/CD)  Full Text
AUTHORS: Joaquim Ferreira; Peter Moore; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS